Hendrix, Philipp http://orcid.org/0000-0003-0017-5049
Gross, Bradley A.
Allahdadian, Sepideh
Sioutas, Georgios S.
Koul, Prateeka
Tarbay, Antonio Corral
Lang, Michael J.
Srinivasan, Visish M.
Al-Bayati, Alhamza R.
Li, Jiang
Noto, Anthony
Nogueira, Raul G.
Burkhardt, Jan-Karl
Zand, Ramin
Schirmer, Clemens M.
Article History
Received: 12 May 2024
Revised: 15 June 2024
Accepted: 17 June 2024
First Online: 3 July 2024
Declarations
:
: BAG is consultant for Medtronic, Microvention, and Stryker. ARA is consultant for Cerenovus and Stryker Neurovascular. RGN reports consulting fees for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Philips, Hybernia, Hyperfine, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, Synchron, and stock options for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, CrestecBio Inc., Euphrates Vascular, Inc., Vesalio, Viz-AI, RapidPulse and Perfuze. RGN is one of the Principal Investigators of the “Endovascular Therapy for Low NIHSS Ischemic Strokes (ENDOLOW)” trial. Funding for this project is provided by Cerenovus. RGN is the Principal Investigator of the “Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe (DUSK)” trial. Funding for this project is provided by Stryker Neurovascular. RGN is an investor in Viz-AI, Perfuze, Cerebrotech, Reist/Q’Apel Medical, Truvic, Tulavi Therapeutics, Vastrax, Piraeus Medical, Brain4Care, Quantanosis AI, and Viseon. JKB is consultant for Stryker, Medtronic, Cerenovus, Microvention, Q’Apel Medical, BALT, Siemens. RZ is partially supported by an NIH-NINDS award (R01NS128986). CMS has research grants from Medtronic, Stryker, Penumbra, Cerenovus, Route 92, MIVI, Balt, Microvention, NICO, NIH/NINDS, and consulting agreements with Medtronic, Stryker, Viz.ai, Balt, Microvention, Werfen and ownership of NTI, Reist.
: The Geisinger IRB approved the study (2022-0571), additional individual site IRBs were in place as well as data use agreements for de-identified data. Consent was waived due to the retrospective nature of the study.